Cargando…

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?

Bacteriocins are bactericidal peptides, ribosomally synthesized, with an inhibitory activity against diverse groups of undesirable microorganisms. Bacteriocins are produced by both gram-positive and gram-negative bacteria, and to a lesser extent by some archaea. Bacteriophages are viruses that are a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopetuso, Loris Riccardo, Giorgio, Maria Ernestina, Saviano, Angela, Scaldaferri, Franco, Gasbarrini, Antonio, Cammarota, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337595/ https://www.ncbi.nlm.nih.gov/pubmed/30621339 http://dx.doi.org/10.3390/ijms20010183

Ejemplares similares

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis
por: Di Vincenzo, Federica, et al.
Publicado: (2022)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
por: Lopetuso, Loris R, et al.
Publicado: (2012)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis
por: Lopetuso, Loris R, et al.
Publicado: (2016)

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
por: Rinninella, Emanuele, et al.
Publicado: (2019)

Digestive Enzyme Supplementation in Gastrointestinal Diseases
por: Ianiro, Gianluca, et al.
Publicado: (2016)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase
por: Papa, Alfredo, et al.
Publicado: (2020)

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
por: Gaetani, Eleonora, et al.
Publicado: (2018)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach
por: Tursi, Antonio, et al.
Publicado: (2022)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Microbiota Composition in Diverticular Disease: Implications for Therapy
por: Tursi, Antonio, et al.
Publicado: (2022)

Synergistic Inhibition by Bacteriocin and Bacteriophage against Staphylococcus aureus
por: Kim, Seon-Gyu, et al.
Publicado: (2019)

Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry
por: Gutiérrez, Diana, et al.
Publicado: (2016)

Bacteriocin as Weapons in the Marine Animal-Associated Bacteria Warfare: Inventory and Potential Applications as an Aquaculture Probiotic
por: Desriac, Florie, et al.
Publicado: (2010)

Inhibition of Clostridium perfringens using Bacteriophages and Bacteriocin Producing Strains
por: Heo, Sunhak, et al.
Publicado: (2018)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

The Effect of a Commercially Available Bacteriophage and Bacteriocin on Listeria monocytogenes in Coleslaw
por: Lewis, Rhea, et al.
Publicado: (2019)

Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection
por: Mondal, Shakhinur Islam, et al.
Publicado: (2020)

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
por: Rinninella, Emanuele, et al.
Publicado: (2020)

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
por: Scaldaferri, Franco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_siilpi7ntu047e1h3mq5d855gs